Investment
Features
FeesSafety
Academy
More
Pluang+

York Water Q1 2026 earnings rise on rate hikes and customer growth

Company Fundamentals
05 May 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

The York Water Company reported a 2026 Q1 net income of $4.8 million, up $1.2 million from 2025, driven by rate increases and a growing customer base. Revenues rose to $20.1 million despite a reset of the Distribution System Improvement Charge to zero. The company invested $9.8 million in infrastructure and acquired two wastewater systems, planning $38.1 million more in 2026 for upgrades and expansions. Lower income taxes helped offset higher expenses, signaling steady growth and ongoing capital improvements.

More News

Baker Hughes Q2 earnings expected to decline but may beat estimates again on strong tech and market conditions

Baker Hughes Q2 earnings expected to decline but may beat estimates again on strong tech and market conditions

Baker Hughes Company is set to report its Q2 2026 earnings with analysts forecasting EPS between $0.49 and $0.51 and revenue around $6.49 to $6.51 billion, both reflecting a year-over-year decline. Despite this, the company has a solid track record o...

Company Fundamentals
Neutral
1 hour ago
Stocks of Faraday Future and Zevra Therapeutics plunge amid regulatory and investor concerns.

Stocks of Faraday Future and Zevra Therapeutics plunge amid regulatory and investor concerns.

Faraday Future Intelligent Electric Inc. saw its stock drop nearly 40% despite recent product showcases, indicating investor worries beyond its new offerings. Zevra Therapeutics' shares fell almost 24% after the European Medicines Agency issued a neg...

Market News
Bearish
1 hour ago
Stocks surge as AI data center plans, IPO debut, and strong earnings drive big gains today

Stocks surge as AI data center plans, IPO debut, and strong earnings drive big gains today

Stocks of several companies jumped significantly today due to key corporate developments. STAK Inc. led with a 596% rise after announcing a U.S. subsidiary to develop power systems for AI data centers, highlighting investor interest in AI infrastruct...

Market News
Bullish
1 hour ago
NovaBridge Biosciences schedules AGM for Sept 8, 2026, highlighting progress in cancer and retinal disease drug development.

NovaBridge Biosciences schedules AGM for Sept 8, 2026, highlighting progress in cancer and retinal disease drug development.

NovaBridge Biosciences announced its annual general meeting (AGM) will be held on September 8, 2026, in Shanghai. The company is advancing clinical-stage biopharmaceutical treatments, including givastomig for gastric cancer and VIS-101 for retinal di...

Company Fundamentals
Neutral
1 hour ago
Pelthos Therapeutics schedules 2026 virtual stockholders meeting for September 29.

Pelthos Therapeutics schedules 2026 virtual stockholders meeting for September 29.

Pelthos Therapeutics announced its 2026 Annual Meeting of Stockholders will be held virtually on September 29, 2026, at 9:00 a.m. Eastern Time. Stockholders of record as of August 4, 2026, are eligible to vote. The company will file the official noti...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App